BioNTech initiates clinical trial of mRNA-based malaria vaccine candidate
BioNTech has initiated a first-in-human Phase 1 clinical trial of its BNT165b1 malaria vaccine candidate using mRNA technology, the German company announced on Friday.
The Phase 1 trial is expected to ...